485 RAFT: A framework to support rapid and reproducible immuno-oncology analyses

485 RAFT: A framework to support rapid and reproducible immuno-oncology analyses

Bibliographic Details
Main Authors:	Benjamin Vincent, Dante Bortone, Steven Vensko
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Immuno-Oncology
by: Swapna Chaudhuri
Published: (2017-01-01)

Raft : automated techniques for diagnosing, reproducing, and fixing concurrency bugs
by: Smith, Steven Oliver
Published: (2014)

Mevalonate Metabolism in Immuno-Oncology
by: Georg Gruenbacher, et al.
Published: (2017-12-01)

Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
by: Kirill Peskov, et al.
Published: (2019-04-01)

Immunotherapies and Combination Strategies for Immuno-Oncology
by: Cody Barbari, et al.
Published: (2020-07-01)

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
by: Jenny Sprooten, et al.
Published: (2020-08-01)

Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo
by: Gitte Holmen Olofsson, et al.
Published: (2020-05-01)

Immunodynamics of explanted human tumors for immuno‐oncology
by: Agathe Dubuisson, et al.
Published: (2021-01-01)

Lights and Shadows in Immuno-Oncology Drug Development
by: Milana Bergamino Sirvén, et al.
Published: (2021-02-01)

Radiotherapy as a New Player in Immuno-Oncology
by: Shang-Jui Wang, et al.
Published: (2018-12-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

Adjuvant therapy with immuno-modulators în oncology
by: Ioana Chitescu, et al.
Published: (2019-05-01)

Immuno-oncology treatment in early stage TNBC
by: S. Loi
Published: (2021-04-01)

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes
by: Gibson EJ, et al.
Published: (2018-03-01)

A perspective on HPK1 as a novel immuno-oncology drug target
by: Sansana Sawasdikosol, et al.
Published: (2020-09-01)

Leveraging NKG2D Ligands in Immuno-Oncology
by: Mercedes Beatriz Fuertes, et al.
Published: (2021-07-01)

Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021-07-01)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
by: Yunxiang Zhou, et al.
Published: (2021-01-01)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
by: Jeong Mo Bae, et al.
Published: (2020-09-01)

Immuno-Oncology Medicines: Policy Implications and Economic Considerations
by: Georges Adunlin, et al.
Published: (2019-08-01)

Novel Nuclear Medicine Imaging Applications in Immuno-Oncology
by: Stefano Frega, et al.
Published: (2020-05-01)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
by: Vida Vafaizadeh, et al.
Published: (2020-03-01)

Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
by: Belinda Lee, et al.
Published: (2019-04-01)

The potential of excipients to improve the efficiency of immuno-oncology therapy.
by: Shireesh Apte

Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
by: Alessandra Cesano, et al.
Published: (2018-02-01)

The potential of excipients to improve the efficiency of immuno-oncology therapy.
by: Shireesh Apte
Published: (2017-09-01)

Immuno-oncology combinations: raising the tail of the survival curve
by: Samuel J. Harris, et al.
Published: (2016-06-01)

Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology
by: Theresa L. Whiteside, et al.
Published: (2021-06-01)

Survey and Rapid detection of Bordetella pertussis in clinical samples targeting the BP485 in China
by: Wei eLiu, et al.
Published: (2015-03-01)

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement
by: Apostolia M. Tsimberidou, et al.
Published: (2018-10-01)

Resurseffektivt bussprotokoll över RS-485
by: Åhman, Alexander
Published: (2015)

Phylogenetic, comparative genomic and structural analyses of human Streptococcus agalactiae ST485 in China
by: Rui Wang, et al.
Published: (2018-09-01)

The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives
by: Aymara Sancho-Araiz, et al.
Published: (2021-07-01)

The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
by: Philippe Merle
Published: (2021-01-01)

Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes
by: Ankush Sharma, et al.
Published: (2017-07-01)

The promise of Immuno-oncology: implications for defining the value of cancer treatment
by: Howard L. Kaufman, et al.
Published: (2019-05-01)

Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology
by: Alberto Signore, et al.
Published: (2019-05-01)

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
by: Jiajia Zhang, et al.
Published: (2018-01-01)

Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize
by: Luís Castelo-Branco, et al.
Published: (2019-04-01)

The hubris and humility of cancer pharmacology in the post immuno‐oncology era
by: John S. Lazo
Published: (2019-12-01)